Individuals in this low-income group were also more likely to have abdominal obesity, hypertension, chronic kidney disease, and a longer duration of T2DM (≥5 years), more likely to use statins, aspirin, oral anti-diabetic medications prescribed per year (at least three), and insulin treatment. The gene discussed is INS; the disease is type 2 diabetes mellitus.